{"source":"clinical-trials","note":"Free 5-item preview. The full feed is $0.05/call at GET /v1/clinical-trials/changes.","question":"Which new clinical trials were registered on ClinicalTrials.gov since T, and which are late-phase or industry-sponsored?","sample":[{"source":"clinical-trials","entityId":"nct:NCT07710859","type":"trial_registered","title":"Interventional: Concentric vs Eccentric Exercise in Blood Flow Restriction Training","summary":"Karabuk University (OTHER) registered NCT07710859 for Exercise, target enrollment 34. Status: ENROLLING_BY_INVITATION.","significance":4,"detectedAt":"2026-07-18T23:39:13.563Z","effectiveDate":"2026-07-17","sourceUrl":"https://clinicaltrials.gov/study/NCT07710859","detail":{"nctId":"NCT07710859","phases":["NA"],"sponsor":"Karabuk University","sponsorClass":"OTHER","conditions":"Exercise","enrollment":34}},{"source":"clinical-trials","entityId":"nct:NCT07712575","type":"trial_registered","title":"Phase 1: A Study of V132 in Healthy Older Participants (V132-001)","summary":"Merck Sharp & Dohme LLC (INDUSTRY) registered NCT07712575 for Healthy, target enrollment 280. Status: NOT_YET_RECRUITING.","significance":5,"detectedAt":"2026-07-18T23:39:13.563Z","effectiveDate":"2026-07-17","sourceUrl":"https://clinicaltrials.gov/study/NCT07712575","detail":{"nctId":"NCT07712575","phases":["PHASE1"],"sponsor":"Merck Sharp & Dohme LLC","sponsorClass":"INDUSTRY","conditions":"Healthy","enrollment":280}},{"source":"clinical-trials","entityId":"nct:NCT07711795","type":"trial_registered","title":"Interventional: Mindfulness Texting for Medication Adherence and Chronic Pain Management","summary":"University of New Mexico (OTHER) registered NCT07711795 for Opioid Use Disorder (OUD), Chronic Pain, target enrollment 60. Status: RECRUITING.","significance":4,"detectedAt":"2026-07-18T23:39:13.563Z","effectiveDate":"2026-07-17","sourceUrl":"https://clinicaltrials.gov/study/NCT07711795","detail":{"nctId":"NCT07711795","phases":["NA"],"sponsor":"University of New Mexico","sponsorClass":"OTHER","conditions":"Opioid Use Disorder (OUD), Chronic Pain","enrollment":60}},{"source":"clinical-trials","entityId":"nct:NCT07710027","type":"trial_registered","title":"Phase 1: Identification of a Safe and Non-Psychedelic Dose of Psilocybin","summary":"Diamond Therapeutics Inc. (INDUSTRY) registered NCT07710027 for Healthy Controls, target enrollment 56. Status: COMPLETED.","significance":5,"detectedAt":"2026-07-18T23:39:13.563Z","effectiveDate":"2026-07-17","sourceUrl":"https://clinicaltrials.gov/study/NCT07710027","detail":{"nctId":"NCT07710027","phases":["PHASE1"],"sponsor":"Diamond Therapeutics Inc.","sponsorClass":"INDUSTRY","conditions":"Healthy Controls","enrollment":56}},{"source":"clinical-trials","entityId":"nct:NCT07711990","type":"trial_registered","title":"Interventional: Effects of Acute Ketone Supplementation on the Brain","summary":"Christopher Crabtree (OTHER) registered NCT07711990 for Brain Health, target enrollment 24. Status: RECRUITING.","significance":4,"detectedAt":"2026-07-18T23:39:13.563Z","effectiveDate":"2026-07-17","sourceUrl":"https://clinicaltrials.gov/study/NCT07711990","detail":{"nctId":"NCT07711990","phases":["NA"],"sponsor":"Christopher Crabtree","sponsorClass":"OTHER","conditions":"Brain Health","enrollment":24}}]}